Recently, poly-pharmacy persistence has greatly improved in treating multiple diseases effectively. However, determining potential drug–drug interaction (DDIs) during the drug design is critical for controlling the target clinical drug during secure testing. In the medical field, DDIs are significant for disease diagnosis and treatment, mainly aiding researchers in predicting the link between biomolecules for efficient drug discovery (DD). Artificial intelligence (AI) has recently witnessed researchers accurately predict DDIs at minimum time consumption. Although the AI models show accurate results by aiding physicians to determine poly-pharmacy, several unresolvable issues remain in promoting reliability due to high error, complexity and cost-effectiveness. This paper aims to provide a comprehensive review using AI techniques (machine learning (ML)–deep learning (DL) models) and security enhancement techniques to improve DDI prediction and DD, respectively. The recent state of DDI prediction and the security concerns are presented initially, along with a short discussion about the need for effective techniques. Then, the critical evaluation related to existing studies is analyzed and compared to current issues faced in those existing studies. Various pharmaceutical drugs and their pros are also surveyed in addition to the security analysis for the newly invented drugs. Several assessment measures for the surveyed techniques are also conquered and put forth the need for advancements in future techniques effectively. The performance variations produced by the existing studies are also surveyed, and their use in the medical industry is also provided in this review study. The review of this research encourages the researchers to analyze the various issues faced in the pharmaceutical industry so that a novel technique can be introduced in the upcoming studies.
Read full abstract